Keywords: اریتروپویتین بازآفرینی انسانی; Recombinant human erythropoietin; Disulfide bond reduction; Electrochemical biosensing; Nanostructured gold electrode; Chronoamperometry; DPV;
مقالات ISI اریتروپویتین بازآفرینی انسانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Recent advances in column coatings for capillary electrophoresis of proteins
Keywords: اریتروپویتین بازآفرینی انسانی; Capillary coating; Dynamic coating; Permanent coating; Nanomaterials; Protein separation; EOF; electroosmotic flow; CE; capillary electrophoresis; LC; liquid chromatography; BFS; bare fused silica; BGE; background electrolyte; SDS; sodium dodecyl sulfate;
Keywords: اریتروپویتین بازآفرینی انسانی; AD-MSCs; adipose tissue-derived mesenchymal stem cells; ANG-1; angiopoietin-1; ANG-2; Angiopoietin-2; ATP; adenosine triphosphate; BBB; blood brain barrier; BDNF; brain-derived neurotrophic factor; BME; β mercaptoethanol; BM-MNCs; bone marrow-derived mon
Keywords: اریتروپویتین بازآفرینی انسانی; recombinant human erythropoietin; biosimilar; immunogenicity; physicochemical properties; protein characterization;
Keywords: اریتروپویتین بازآفرینی انسانی; Cerebral palsy; Recombinant human erythropoietin; Anti-inflammatory effect; Neurodevelopment
Keywords: اریتروپویتین بازآفرینی انسانی; ADC; Apparent diffusion coefficient; DWI; Diffusion-weighted imaging; EPO; Erythropoietin; MCA; Middle cerebral artery; MRI; Magnetic resonance imaging; PCA; Posterior cerebral artery; rhEPO; Recombinant human erythropoietin; TE; Echo time; TR; Repetition
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model
Keywords: اریتروپویتین بازآفرینی انسانی; hpf; hours post fertilization; dpf; days post fertilization; CHO; Chinese hamster ovary; EPO; erythropoietin; EPOR; erythropoietin receptor; rhEPO; recombinant human erythropoietin; hepo; human erythropoietin gene; hEPO; human erythropoietin protein; hEPO
A novel reporter gene assay for Recombinant Human Erythropoietin (rHuEPO) pharmaceutical products
Keywords: اریتروپویتین بازآفرینی انسانی; Recombinant human erythropoietin; Biological activity; Reticulocyte assay; In vitro bioassay; Reporter gene assay;
Enteral Granulocyte-Colony Stimulating Factor and Erythropoietin Early in Life Improves Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial
Keywords: اریتروپویتین بازآفرینی انسانی; ARR; Absolute risk reduction; EPO; Erythropoietin; G-CSF; Granulocyte colony-stimulating factor; NEC; Necrotizing enterocolitis; rhEPO; Recombinant human erythropoietin; rhG-CSF; Recombinant human granulocyte colony-stimulating factor; TPN; Total parenter
Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line
Keywords: اریتروپویتین بازآفرینی انسانی; EPO; erythropoietin; IFN; interferon; IL-3; interleukin-3; NAb; neutralizing antibodies; PNHS; pooled normal human sera; PRCA; pure red cell aplasia; rHuEPO; recombinant human erythropoietin; Erythropoietin; Neutralizing antibodies; EGR1; Pure red cell ap
Recombinant human erythropoietin preconditioning attenuates liver ischemia reperfusion injury through the phosphatidylinositol-3 kinase/AKT/endothelial nitric oxide synthase pathway
Keywords: اریتروپویتین بازآفرینی انسانی; Recombinant human erythropoietin; Ischemia/reperfusion; Liver; Protein kinase B; Endothelial nitric oxide synthase
Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma
Keywords: اریتروپویتین بازآفرینی انسانی; Blood doping; Recombinant human erythropoietin; MAIIA;
Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer
Keywords: اریتروپویتین بازآفرینی انسانی; Recombinant human erythropoietin; Protein stabilization; Microspheres; Solid-in-oil-in-water (s/o/w) emulsion method; Human serum albumin
The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats
Keywords: اریتروپویتین بازآفرینی انسانی; JAK2; STAT3; Anti-apoptotic; Recombinant human erythropoietin; Traumatic brain injury;
Anaemia of prematurity: Pathophysiology and treatment
Keywords: اریتروپویتین بازآفرینی انسانی; Anaemia of prematurity; Neonatal RBC transfusions; Recombinant human erythropoietin; Neonatal transfusion outcomes
A validated capillary electrophoresis method to check for batch-to-batch consistency during recombinant human glycosylated interleukin-7 production campaigns
Keywords: اریتروپویتین بازآفرینی انسانی; BGE; background electrolyte; CE; capillary electrophoresis; CHO; Chinese Hamster Ovary; CZE; capillary zone electrophoresis; DAB; diaminobutane; E. coli; Escherichia coli; EOF; electroosmotic flow; Eu. Ph.; European pharmacopoeia; ICH; International Confe
Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury
Keywords: اریتروپویتین بازآفرینی انسانی; Akt/PKB; a serine/threonine protein kinase B; BBB; Blood Brain Barrier; BrdU; Bromodeoxyuridine; BDNF; Brain-derived neurotrophic factor; CCI; Controlled cortical impact; CREB; CyclicAMP responsive element binding protein; CNS; Central nervous system; eNO
¿Eritropoyetina humana recombinante, ¿Una alternativa válida para el tratamiento de la anemia del paciente crítico?
Keywords: اریتروپویتین بازآفرینی انسانی; Pacientes críticos; Anemia; Transfusión alogénica; Eritropoyetina recombinante; Deficiencia funcional de hierro; Hierro intravenoso; TromboprofilaxisCritically ill patients; Anaemia; Allogeneic blood transfusion; Recombinant human erythropoietin; Function
Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis
Keywords: اریتروپویتین بازآفرینی انسانی; EPCs; endothelial progenitor cells; EPO; erythropoietin; CKD; chronic kidney disease; rHuEPO; recombinant human erythropoietin; darbe; darbepoetin; C-darbe; carbamylated darbepoetin; TNBSA; trinitrobenzenesulfonic acid; PCNA; proliferating cell nuclear an
Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia
Keywords: اریتروپویتین بازآفرینی انسانی; AVLT; Auditory Verbal Learning Test; CPZ; chlorpromazine; CSF; cerebrospinal fluid; DCS; Diagnostic Test of Cerebral Dysfunction; H; high S100B serum level; L; low S100B serum level; PANSS; Positive and Negative Syndrome Scale; rhEPO; recombinant human er
Protective effect of erythropoietin against aristolochic acid-induced apoptosis in renal tubular epithelial cells
Keywords: اریتروپویتین بازآفرینی انسانی; Recombinant human erythropoietin; Aristolochic acid; LLC-PK1 cell; Apoptosis; Renoprotective effect;
Ãpargne transfusionnelle en chirurgie orthopédique
Keywords: اریتروپویتین بازآفرینی انسانی; Transfusion autologue; Ãrythropoïétine humaine recombinante; Antifibrinolytiques; Autologous transfusion; Recombinant human erythropoietin; Antifibrinolytics;
EPO Adjustments in Patients With Elevated Hemoglobin Levels: Provider Practice Patterns Compared With Recommended Practice Guidelines
Keywords: اریتروپویتین بازآفرینی انسانی; Hematocrit; hemodialysis (HD); hemoglobin; recombinant human erythropoietin;
Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease
Keywords: اریتروپویتین بازآفرینی انسانی; neuroprotection; inflammation; immunocytochemistry; striatum; substantia nigra; tyrosine hydroxylase; Alb; albumin; ANOVA; factor analysis of variance; CR3; complement receptor type 3; DAT; dopamine transporter; EPO; erythropoietin; GFAP; glial fibrillary
Darbepoetin Alfa Administration to Achieve and Maintain Target Hemoglobin Levels for 1 Year in Patients With Chronic Kidney Disease
Keywords: اریتروپویتین بازآفرینی انسانی; CI; confidence interval; CKD; chronic kidney disease; ESP; erythropoiesis-stimulating protein; GFR; glomerular filtration rate; MDRD; Modification of Diet in Renal Disease; NKF-KDOQI; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia
Keywords: اریتروپویتین بازآفرینی انسانی; Recombinant human erythropoietin; Intranasal delivery; Cerebral ischemia; Neuroprotection;
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review
Keywords: اریتروپویتین بازآفرینی انسانی; cancer therapy; recombinant human erythropoietin; systematic review;
Current concepts in critical care
Keywords: اریتروپویتین بازآفرینی انسانی; PAC; pulmonary artery catheter; rHuEpo; recombinant human erythropoietin; SBT; spontaneous breathing trial;
Immunologic mechanisms of EPO-associated pure red cell aplasia
Keywords: اریتروپویتین بازآفرینی انسانی; pure red cell aplasia; recombinant human erythropoietin; native erythropoietin;
Cardiovascular Toxicities of Performance-Enhancing Substances in Sports
Keywords: اریتروپویتین بازآفرینی انسانی; AAS; anabolic-androgenic steroids; ATP; adenosine triphosphate; FDA; Food and Drug Administration; HDL; high-density lipoprotein; hGH; human growth hormone; HMB; β-hydroxy-β-methylbutyrate; LDL; low-density lipoprotein; rhEPO; recombinant human erythrop
The detection of anti-erythropoietin antibodies in human serum and plasma
Keywords: اریتروپویتین بازآفرینی انسانی; Anemia; Erythropoietin; Neutralizing anti-erythropoietin antibodies; Cytokines; Radioimmunoprecipitation; Stem cell factor; Thymidine uptake; UT-7/EPO; Bioassay; Ab; antibody; BQL; below quantifiable limits; CRF; chronic renal failure; % CV; percent coeff
FIV-infected cats respond to short-term rHuG-CSF treatment which results in anti-G-CSF neutralizing antibody production that inactivates drug activity
Keywords: اریتروپویتین بازآفرینی انسانی; BM; bone marrow; CID50; cat median infectious dose; CI; confidence interval; ED50; efficacy dose 50%; FIV; feline immunodeficiency virus; FIP; feline infectious peritonitis; M:E; myeloid:erythroid; rHuEPO; recombinant human erythropoietin; rHuG-CSF; recom